EDAP TMS SA/ US2683111072 /
| 24/05/2024 21:44:44 | Chg. +0.09 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 6.12USD | +1.41% | 693 Turnover: 4,227.73 |
-Bid Size: - | -Ask Size: - | 6.13 | 6.07 |
GlobeNewswire
06/05
EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Vers...
GlobeNewswire
23/04
EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Pr...
GlobeNewswire
13/03
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
GlobeNewswire
06/03
EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
GlobeNewswire
04/03
EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrat...
GlobeNewswire
01/02
EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the T...
GlobeNewswire
08/01
EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
GlobeNewswire
02/01
EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Account...
GlobeNewswire
12/12/2023
EDAP Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS...
GlobeNewswire
30/11/2023
EDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Prope...
GlobeNewswire
26/10/2023
EDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023
GlobeNewswire
06/09/2023
EDAP to Present at Morgan Stanley Annual Global Healthcare Conference and the H.C. Wainwright Annual...
GlobeNewswire
21/03/2022
EDAP TMS SA to Announce Fourth Quarter 2021 Financial Results on Wednesday, March 30, 2022
